Mesalamine - NDC Database (Page 4)

77 records found
Page:First PagePrevious Page4
68382-435 Aug 02, 2018
Mesalamine 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
68382-452 Aug 13, 2021
Mesalamine .375 g/1 Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
68682-113 Jul 19, 2018
Mesalamine 375 mg Oral Capsule, Extended Release by Oceanside Pharmaceuticals
69238-1274 Jan 08, 2020
Mesalamine 1000 mg Rectal Suppository by Amneal Pharmaceuticals Ny LLC
69918-560 Jun 24, 2019
Mesalamine Rectal Rectal 1000 mg Rectal Suppository by Amring Pharmaceuticals Inc.
70518-3239 Oct 13, 2021
Mesalamine 400 mg Oral Capsule, Delayed Release by Remedyrepack Inc.
70710-1302 Feb 14, 2020
Mesalamine 1000 mg Rectal Suppository by Zydus Pharmaceuticals (Usa) Inc.
70710-1543 Jan 17, 2019
Zaldyon 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.
70748-214 May 18, 2020
Mesalamine 375 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
70771-1110 Aug 02, 2018
Mesalamine 800 mg Oral Tablet, Delayed Release by Cadila Healthcare Limited
70771-1353 Jan 17, 2019
Zaldyon 800 mg Oral Tablet, Delayed Release by Cadila Healthcare Limited
70771-1513 Feb 14, 2020
Mesalamine 1000 mg Rectal Suppository by Cadila Healthcare Limited
70771-1625 Aug 13, 2021
Mesalamine .375 g/1 Oral Capsule, Extended Release by Cadila Healthcare Limited
72162-1804 Jun 05, 2019
Mesalamine 1000 mg Rectal Suppository by Bryant Ranch Prepack
72162-2213 Jun 03, 2023
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Bryant Ranch Prepack
72162-2231 Mar 26, 2018
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Bryant Ranch Prepack
75929-137 Jul 19, 2018
Mesalamine 375 mg Oral Capsule, Extended Release by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
Page:First PagePrevious Page4
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.